LipoSonix,
Inc.
LipoSonix focuses on providing a non-invasive alternative to liposuction surgery using High Intensity Focused Ultrasound (HIFU) technology.
Coinvestors include Three Arch Partners, Versant Ventures, Delphi Ventures, Carlyle Venture Partners, Essex Woodlands Health Ventures, Pinnacle Ventures and SV Life Sciences.
NeoVista,
Inc.
NeoVista is developing a radiation therapy for the wet form of age related macular degeneration (AMD).
Coinvestors include Versant Ventures, Carlyle Venture Partners, Essex Woodlands Health Ventures, SV Life Sciences and MPM Capital.
AcuFocus,
Inc.
AcuFocus has developed an innovative corneal implant technology to treat presbyopia.
Coinvestors include Versant Ventures, Carlyle Venture Partners, SV Life Sciences, Pequot Ventures and Bausch & Lomb.
Inogen,
Inc.
Inogen builds and sells low-weight, portable oxygen (O2) concentrators to serve as full-time replacement devices for the O2 home market.
Coinvestors include Versant Ventures, Novo Ventures, Arboretum Ventures and Avalon Ventures.
Cellutions,
Inc.
Cellutions is an early stage company formed by The Innovation Factory (www.tif.net) to treat cellulite, a condition that affects 90% of post-adolescent females.
Coinvestors include Versant Ventures, Carlyle Venture Partners and SV Life Sciences.
Neuronetics,
Inc.
Neuronetics is developing a non-invasive medical technology to treat depression using Transcranial Magnetic Stimulation (TMS).
Coinvestors include Three Arch Partners, InterWest Partners, ONSET Ventures, Quaker Bioventures, KBL Healthcare Ventures and Investor AB.
OsteoLign
OsteoLign is an early stage company founded by The Innovation Factory with a minimally invasive solution for long bone fractures.
Coinvestors include Versant Ventures and SV Life Sciences.
AxoGen
AxoGen provides surgeons a biological solution to repair and regenerate peripheral nerves, bringing relief and restoring functionality to patients who suffer peripheral nerve injuries.
Coinvestors include De Novo Ventures and Cardinal Partners and SpringBoard.
CardioFocus
CardioFocus is developing a catheter based approach to treating atrial fibrillation.
Coinvestors include Oxford Biosciences, SV Life Sciences, H.I.G. Ventures, Aurora Funds and KBL Healthcare Ventures
MyoScience
MyoScience is developing novel technologies for aesthetic medicine.
Coinvestors include De Novo Ventures and Saratoga Ventures.
SoftScope
Softscope is developing a disposable accessory for use with existing colonoscopes that will make colonoscopy more comfortable for patients, easier and faster for physicians and potentially eliminate the need for I.V. sedation.
Coinvestors include Thomas, McNerney and Partners.
Cardiac Concepts
Early stage medical device company developing a neurostimulation technology to treat Congestive Heart Failure patients with Central Sleep Apnea.
Coinvestors include Three Arch Partners, Affinity Capital and RKV Ventures Group.
AqueSys
AqueSys is developing a novel drainage shunt to lower intraocular pressure to relieve symptoms of glaucoma.
Coinvestors include SV Life Sciences and Carlyle Ventures.
WaveTec
Vision
WaveTec Vision is developing ORange™, a novel wavefront measurement technology that provides on-demand, intraoperative information to the refractive cataract surgeon.
Coinvestors include Versant Ventures and De Novo Ventures.
Halscion
Halscion is an early stage company developing a novel technology to treat a common dermatological condition.
Coinvestors include Versant Ventures and SV Life Sciences.
